When to Get Off the Sidelines - A SOPE and WBP Collaborative Event

Wednesday, April 10, 2019, 6-9 pm EST at Manhattanville College

SOPE When to Get Off the Sidelines.jpeg

Scott Locke, Esq., Partner & Chair of the Intellectual Property Department - Dorf & Nelson

In collaboration with the Society of Physician Entrepreneurs, we dive into the logistics of the entrepreneurial process to help you identify when the right time would be to turn your idea into a new business.

Many established professionals are also aspiring entrepreneurs nurturing an idea with real market potential. However, the necessary preparation and insight needed for a new venture is not trivial. Guidance on the topics that need to be well thought out and established, along with obstacles you should expect and be ready to manage, will be presented.

About the Society of Physician Entrepreneurs:

The Society of Physician Entrepreneurs (SoPE) is a global biomedical and healthcare innovation network with membership open to all healthcare professionals, entrepreneurs and industry stakeholders. SoPE was founded in 2011 by three physicians who shared a common vision - to empower physicians and other professionals to innovate healthcare through entrepreneurship. SoPE continues to gain momentum across the United States, Turkey, China and the United Arab Emirates, as well as with industry partners who directly support our members' efforts. Members include doctors, nurses, dentists, healthcare entrepreneurs, investors, engineers, academics, IT professionals and industry representatives.

Scott Locke.jpg

About Our Speaker:

Scott Locke counsels clients on the procurement, enforcement, and licensing of patents, trademarks, copyrights, and trade secrets. He provides solo inventors, start-up businesses, and well-established companies across diverse industries with strategies and tools for maximizing the return on their investment in their ingenuity, creativity, and goodwill. His clients include innovators in the fields of pharmaceuticals, delivery systems, diagnostics, siRNA technologies, Cas9 related technologies, gene therapies, and medical devices.